ReviewAmerican journal of clinical dermatology2026

Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis.

César Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.